Thomas, Mike
Bateman, Eric
Article History
First Online: 8 January 2015
Competing interests
: Neither MT nor any member of his close family has any shares in pharmaceutical companies. In the last 3 years he has received speaker's honoraria for speaking at sponsored meetings or satellite symposia at conferences from the following companies marketing respiratory and allergy products: Aerocrine, Astra Zeneca, Boehringer Inglehiem, GSK, MSD, Teva. He has received honoraria for attending advisory panels with; Aerocrine, Almirall, Astra Zeneca, BI, Chiesi, GSK, MSD, Novartis. He has received sponsorship to attend international scientific meetings from: GSK, Astra Zeneca, Mundipharma. He has received funding for research projects from: GSK, Almirall. He is chief medical adviser to the charity Asthma UK, a member of the BTS SIGN Asthma guideline group and the NICE Asthma guideline group.EB reports personal fees for consulting and advisory board membership from Actelion, Almirall, AstraZeneca, Boehringer Ingelheim, and Hoffman la Roche; personal fees for advisory board membership from ALK-Abello, Chiesi, Elevation Pharma, Forest, Glaxo SmithKline, Napp Pharma, Navigant Consulting, Novartis, Pfizer, IMS Consulting Group, Takeda, and ICON; personal fees for lectures from AstraZeneca, Boehringer Ingelheim, Chiesi, Glaxo SmithKline, Merck, Novartis, Pfizer and Takeda; personal fees for educational materials from PeerVoice and Indegene; and grants to his institution for participation in clinical trials sponsored by Actelion, Aeras, Almirall, AstraZeneca, Boehringer Ingelheim, Cephalon, Chiesi, Glaxo SmithKline, Hoffman la Roche, Merck, Nycomed, Takeda, TEVA and Sanofi-Aventis outside the submitted work. He is a member of the Board of the Global Initiative for Asthma (GINA). Neither he nor any member of his close family has shares in a pharmaceutical company.